Truist Securities on Viking Therapeutic (VKTX): 'Data Looks Clean On Safety/Tolerability'
Tweet Send to a Friend
Truist Securities analyst Joon Lee reiterated a Buy rating and $32.00 price target on Viking Therapeutic (NASDAQ: VKTX).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
